Seeing Is Believing
Currently out of the existing stock ratings of John Walsh, 99 are a HOLD (34.62%), 168 are a BUY (58.74%), 19 are a SELL (6.64%).
Analyst John Walsh, carries an average stock price target met ratio of 65.67% that have a potential upside of 24.66% achieved within 304 days. Previously, John Walsh worked at CREDIT SUISSE.
John Walsh’s has documented 580 price targets and ratings displayed on 37 stocks. The coverage was on Industrials, Technology, Basic Materials, Healthcare sectors.
Most recent stock forecast was given on PNT, POINT Biopharma Global at 04-Oct-2023.
Analyst best performing recommendations are on GTLS (CHART INDUSTRIES).
The best stock recommendation documented was for GTLS (CHART INDUSTRIES) at 10/13/2020. The price target of $80 was fulfilled within 1 day with a profit of $4.69 (6.23%) receiving and performance score of 62.28.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$185
$7.71 (4.35%)
$163
7 days ago
(30-Sep-2025)
23/31 (74.19%)
$8.27 (4.68%)
278
Buy
$198
$20.71 (11.68%)
$170
22 days ago
(15-Sep-2025)
7/8 (87.5%)
$20.96 (11.84%)
546
Hold
$175
$-2.29 (-1.29%)
$110
2 months 9 days ago
(28-Jul-2025)
7/7 (100%)
$11.37 (6.95%)
492
Hold
$175
$-2.29 (-1.29%)
$150
2 months 13 days ago
(24-Jul-2025)
18/18 (100%)
$10.09 (6.12%)
370
Hold
$155
$-22.29 (-12.57%)
$145
2 months 13 days ago
(24-Jul-2025)
11/12 (91.67%)
$-9.91 (-6.01%)
385
What Year was the first public recommendation made by John Walsh?